2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (Updating the 2005 guideline)
2011 WRITING GROUP MEMBERS*(Association of Chartered Certified Accountants), Yancy Cw, Ziv J. Haskal, David B. Sacks(National Institutes of Health Clinical Center), Laura Findeiss(American Heart Association), Thom W. Rooke(American Heart Association), Alice K. Jacobs(Boston Medical Center), William R. Murphy(American College of Cardiology), Norman Hertzer(Cleveland Clinic), E. Magnus Ohman(Duke University), Jules B. Puschett(American College of Cardiology), R. Eugene Zierler, Jeffrey W. Olin(Icahn School of Medicine at Mount Sinai), Loren F. Hiratzka(Bethesda North Hospital), Sanjay Misra(Mayo Clinic), Michael R. Jaff(Boston Scientific (United States)), Nancy M. Albert(Cleveland Clinic), Gregory L. Moneta(Oregon Health & Science University), Frederick G. Kushner, Joshua A. Beckman(Clinical Research Institute), Judith S. Hochman(New York University), James C. Stanley(University of Michigan), Jeffrey L. Anderson(Intermountain Medical Center), Christopher J. White(Ochsner Medical Center), Jafar Golzarian(University of Minnesota), Kenneth A. Rosenfield(American College of Cardiology), Jonathan L. Halperin, Lloyd M. Taylor, Robert A. Guyton(American College of Cardiology), Steven M. Ettinger(Pennsylvania State University), Curtis W. Bakal(St. Luke's-Roosevelt Hospital Center), John V. White(Advocate Lutheran General Hospital), Mark A. Creager(Society for Vascular Surgery), Anton N. Sidawy(George Washington University Hospital), Alan T. Hirsch(University of Minnesota Medical Center), Christopher J. White(Association of Chartered Certified Accountants), Rodney A. White(American College of Cardiology), ACCF/AHA TASK FORCE MEMBERS(American College of Cardiology), William G. Stevenson(Vanderbilt University Medical Center), Heather L. Gornik(Asia Society)
Cited by 86
Related Papers
Markers of Inflammation and Cardiovascular Disease
|Circulation|2003|6.3k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients
|New England Journal of Medicine|2004|2.9k